Icon

DEFITELIO (nda208114)- (200MG/2.5ML (80MG/ML))

DEFIBROTIDE SODIUM JAZZ PHARMS INC
200MG/2.5ML (80MG/ML)
No No
2032-Jun-22 2021-Mar-30
2023-Mar-30 None
None No
DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT).
0 0 0
Total Other Developers None
Drugs with Suitability No
200MG/2.5ML (80MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.